Goldman Sachs Group Inc Endo International PLC Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$0.3 - $2.74 $861,318 - $7.87 Million	2,871,062 New	2,871,062 $1.34 Million
Q2 2022 Aug 15, 2022	SELL	$0.3 - $2.74 $14,055 - $128,374	-46,852 Reduced 1.61%	2,871,062 $1.34 Million
Q1 2022 May 16, 2022	SELL	$2.13 - $3.85 $78,607 - $142,084	-36,905 Reduced 1.25%	2,917,914 $6.74 Million
Q4 2021 Feb 14, 2022	BUY	$3.39 - $6.76 $5.99 Million - $12 Million	1,768,067 Added 148.98%	2,954,819 $11.1 Million
Q3 2021 Nov 10, 2021	BUY	$2.1 - $5.19 $2.49 Million - $6.16 Million	1,186,752 New	1,186,752 $3.85 Million

Ticker ENDP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 235,143,008
Market Cap $68.8M
Description
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.